about
Squamous cell carcinoma of the pancreas: A systematic review and pooled survival analysis.The Emerging Role of Tyrosine Kinase Inhibitors in Ovarian Cancer Treatment: A Systematic Review.The role of BioGlue in thoracic surgery: a systematic reviewAdipose-derived stem cells for breast reconstruction after breast surgery - preliminary results.Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis.Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review.Esophageal remnant cancer 35 years after acidic caustic injury: A case report.The Role of Endoscopic Ultrasound in the Diagnosis and Management of Primary Gastric Lymphoma.Combined Use of Mammography and FNA Eliminates Pitfalls in the Management of Metaplastic Breast CarcinomaManagement and Outcomes in Metaplastic Breast Cancer.Physical Activity and Gastric Cancer Risk: A Systematic Review and Meta-Analysis.Association between problematic internet use, socio-demographic variables and obesity among European adolescents.Consumption of fruits, vegetables, and risk of hematological malignancies: a systematic review and meta-analysis of prospective studies.Intraductal papilloma of the breast in an 11-year-old male patient: a case report.Challenging differential diagnosis of an extra-adrenal paraganglioma; the role of fine needle aspiration cytology.Corrigendum to "Esophageal remnant cancer 35 years after acidic caustic injury: A case report" [Int. J. Surg. Case Rep. 25 (2016) 215-217].Endobronchial Carcinoid Tumor Totally Occluding the Left Main Bronchus Without Producing Symptoms of Bronchial Obstruction.Clear cell "sugar tumor" of the lung: Diagnostic features of a rare pulmonary tumor.Impact of Surgical Margin Width on Recurrence and Overall Survival Following R0 Hepatic Resection of Colorectal Metastases: A Systematic Review and Meta-analysis.Updates and Critical Insights on Glissonian Approach in Liver Surgery.The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents.Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic review.Neuroendocrine Neoplasms of the Appendix: A Review of the Literature.Alcohol consumption and risk of hematological malignancies: A meta-analysis of prospective studies.Rare manifestations of extramedullary myeloma: testicular plasmacytomas.Program death-1 immune checkpoint and tumor microenvironment in malignant liver tumors.Insulin resistance and cardiometabolic risk factors in obese children and adolescents: a hierarchical approach.Update on Surgical Management of Small Bowel Neuroendocrine Tumors.Challenging management of synchronous cancers presenting with dysphagia.Insights into Novel Prognostic and Possible Predictive Biomarkers of Lung Neuroendocrine Tumors.Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidenceCoexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional casesDenosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trialCirculating Soluble Receptor Activator of Nuclear Factor Kappa B Ligand and C-C Motif Ligand 3 Correlate With Survival in Patients With Waldenström MacroglobulinemiaConsolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with muDetection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathiesScreening for Gaucher disease among patients with plasma cell dyscrasiasConsolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonatesReal-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
P50
Q30234439-EA474B97-695D-4C86-A48E-F67496A47303Q30248645-7F74CE1D-3089-4606-AFFC-AA9E682B1348Q33571120-4A0CBCC6-13E7-4100-8E5C-36266338EEDAQ33601974-C1E3DE8B-00B4-460C-880B-9E549D409695Q35762521-0D77BE77-3967-4C29-B745-12200BE32521Q36408076-41C5B244-506A-4071-9EC2-D53D7EB9A875Q37085494-F38122DE-7405-4DBB-B921-C897B9456CD8Q37733616-FC9D4342-BC9E-457C-8DE5-1A72BC3057FAQ38707991-33C94CDF-52FF-4EBB-B6E3-824EF72646DBQ38840364-D507D560-FB3E-4066-8C2F-DA89333EDF79Q38878198-0CF63FAC-F7E2-448D-A4E1-5863269443C3Q39822105-78D76C28-039C-4D80-A0AC-A56C05843194Q40067756-B33AF9A5-A274-4EF1-BF5B-934AA1BDE083Q40269184-6A76E62F-0B75-42F6-B395-683CA373DE5DQ40307430-B41FC1E7-6E81-4D9E-BA41-7D86E669C018Q42374698-548CDB9D-BA41-4C91-8224-244AA01D14C2Q44259901-7E79D821-1058-4051-B01B-F08E4862C862Q47164814-8F45CCDA-0460-4920-9FC3-AE20E89F1A1CQ47392655-210895A4-26A7-461E-9D3A-663E8BF3D381Q47860447-CE68EE0A-0A68-40A2-AB17-32715AB198FDQ48001672-998C81A4-1683-428B-897A-601B2EB26945Q48251592-D8370CD8-3342-49C2-99C6-1F2FA0760E1CQ48342432-53DDBFDB-9A85-4499-94BA-08F9A40C35C2Q48521927-59F6A0E8-39D2-4FD3-8BCF-8B866A7F7D50Q49822475-F13CA641-859A-4FBB-A28E-844B00DD72EBQ50038926-32206235-A60A-4DDC-A8F8-453616FACB65Q50118274-2375ABB4-F03B-4F99-9C51-50FFEC2584D5Q50577928-71FDD7E8-6E1B-41E5-97AB-A73AB14D73C4Q51737297-E09D5B84-8453-4BE3-A343-4C32FB8BB785Q52946711-3E0ECBC3-72A9-4D9A-BDCA-21F7E836D20FQ55141745-992523E3-0D85-4CE6-B525-6824042B066AQ57781151-CDC2A2CC-65AB-47AD-B19C-B8E605121617Q57904139-5DAB2501-5856-48D3-BBEF-712A1BC3481DQ58076952-FEA6053D-7F7D-42BE-965C-2FE1714DB2B2Q88444961-09CB1E91-190B-4B97-A9F3-9327891D201DQ89983190-6FDA1344-46DD-446E-8228-559C3C8CAB3FQ90351128-4831EA75-D739-46DE-BDCF-76E56E7CAF3AQ90364038-69AEC945-2CA8-4E0A-95AB-25B290B0F46EQ90787473-94AA4C17-F610-4D4E-B0D4-1F687830557AQ90821787-87DFBA73-5A34-4CDA-9B7F-E6051CE26C83
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ioannis Ntanasis-Stathopoulos
@ast
Ioannis Ntanasis-Stathopoulos
@en
Ioannis Ntanasis-Stathopoulos
@es
Ioannis Ntanasis-Stathopoulos
@sl
type
label
Ioannis Ntanasis-Stathopoulos
@ast
Ioannis Ntanasis-Stathopoulos
@en
Ioannis Ntanasis-Stathopoulos
@es
Ioannis Ntanasis-Stathopoulos
@sl
altLabel
John Ntanasis-Stathopoulos
@en
prefLabel
Ioannis Ntanasis-Stathopoulos
@ast
Ioannis Ntanasis-Stathopoulos
@en
Ioannis Ntanasis-Stathopoulos
@es
Ioannis Ntanasis-Stathopoulos
@sl
P106
P1153
56624542300
P21
P31
P496
0000-0002-6328-9783